Literature DB >> 32968798

Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade.

Ashmita Dey1, Sagnik Sen1, Ujjwal Maulik1.   

Abstract

The novel coronavirus or COVID-19 has first been found in Wuhan, China, and became pandemic. Angiotensin-converting enzyme 2 (ACE2) plays a key role in the host cells as a receptor of Spike-I Glycoprotein of COVID-19 which causes final infection. ACE2 is highly expressed in the bladder, ileum, kidney and liver, comparing with ACE2 expression in the lung-specific pulmonary alveolar type II cells. In this study, the single-cell RNAseq data of the five tissues from different humans are curated and cell types with high expressions of ACE2 are identified. Subsequently, the protein-protein interaction networks have been established. From the network, potential biomarkers which can form functional hubs, are selected based on k-means network clustering. It is observed that angiotensin PPAR family proteins show important roles in the functional hubs. To understand the functions of the potential markers, corresponding pathways have been researched thoroughly through the pathway semantic networks. Subsequently, the pathways have been ranked according to their influence and dependency in the network using PageRank algorithm. The outcomes show some important facts in terms of infection. Firstly, renin-angiotensin system and PPAR signaling pathway can play a vital role for enhancing the infection after its intrusion through ACE2. Next, pathway networks consist of few basic metabolic and influential pathways, e.g. insulin resistance. This information corroborate the fact that diabetic patients are more vulnerable to COVID-19 infection. Interestingly, the key regulators of the aforementioned pathways are angiontensin and PPAR family proteins. Hence, angiotensin and PPAR family proteins can be considered as possible therapeutic targets. Contact: sagnik.sen2008@gmail.com, umaulik@cse.jdvu.ac.in Supplementary information: Supplementary data are available online.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32968798      PMCID: PMC7543283          DOI: 10.1093/bib/bbaa214

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  5 in total

1.  Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm.

Authors:  Huawei Li; Jia You; Xi Yang; Yuanfeng Wei; Lingnan Zheng; Yaqin Zhao; Ying Huang; Zhao Jin; Cheng Yi
Journal:  Phytomedicine       Date:  2022-05-13       Impact factor: 6.656

Review 2.  Liver injury in the era of COVID-19.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2021-02-07       Impact factor: 5.742

3.  Topological analysis for sequence variability: Case study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countriesvin comparison with SARS-CoV-1 and MERS-CoV.

Authors:  Jnanendra Prasad Sarkar; Indrajit Saha; Arijit Seal; Debasree Maity; Ujjwal Maulik
Journal:  Infect Genet Evol       Date:  2021-01-06       Impact factor: 3.342

Review 4.  Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment.

Authors:  Yuling Huang; Xin Li; Lina Yang
Journal:  Stem Cell Res Ther       Date:  2022-08-12       Impact factor: 8.079

Review 5.  Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets.

Authors:  Rittibet Yapasert; Patompong Khaw-On; Ratana Banjerdpongchai
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.